Related Experiment Videos
Vaccines against hantaviruses
1Center for Emerging Infectious Diseases, Department of Pathology, University of New Mexico School of Medicine, Albuquerque 87131, USA. bhjelle@salud.unm.edu
Expert Review of Vaccines
|August 7, 2003
Summary
Hantaviruses cause severe diseases like hemorrhagic fever with renal syndrome and hantavirus cardiopulmonary syndrome. Developing polyvalent vaccines is crucial due to the genetic diversity of these rodent-borne viruses.
Area of Science:
- Virology
- Vaccinology
- Infectious Diseases
Background:
- Rodent-borne hantaviruses cause severe hemorrhagic fever with renal syndrome (HFRS) and hantavirus cardiopulmonary syndrome (HCPS).
- These diseases, while uncommon globally, present significant public health challenges.
- Hantaviruses exhibit substantial genetic variability, complicating vaccine development.
Purpose of the Study:
- To review the current status of hantavirus vaccines.
- To consider conventional and novel vaccine technologies for hantavirus prevention.
Main Methods:
- Literature review of existing hantavirus vaccine research.
- Analysis of vaccine technologies applicable to genetically diverse viruses.
Main Results:
- Current hantavirus vaccines are limited in scope due to viral genetic diversity.
- Polyvalent vaccines are likely necessary for broad cross-protection.
- Various conventional and speculative vaccine approaches are under consideration.
Conclusions:
- Effective hantavirus vaccines require addressing significant viral genetic variability.
- Future vaccine strategies may involve polyvalent approaches and innovative technologies.